AU2001292137A1 - Quinazoline derivatives - Google Patents
Quinazoline derivativesInfo
- Publication number
- AU2001292137A1 AU2001292137A1 AU2001292137A AU9213701A AU2001292137A1 AU 2001292137 A1 AU2001292137 A1 AU 2001292137A1 AU 2001292137 A AU2001292137 A AU 2001292137A AU 9213701 A AU9213701 A AU 9213701A AU 2001292137 A1 AU2001292137 A1 AU 2001292137A1
- Authority
- AU
- Australia
- Prior art keywords
- quinazoline derivatives
- quinazoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00402845 | 2000-10-13 | ||
| EP00402845 | 2000-10-13 | ||
| PCT/GB2001/004497 WO2002030926A1 (en) | 2000-10-13 | 2001-10-09 | Quinazoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001292137A1 true AU2001292137A1 (en) | 2002-04-22 |
Family
ID=8173902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001292137A Abandoned AU2001292137A1 (en) | 2000-10-13 | 2001-10-09 | Quinazoline derivatives |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6939866B2 (en) |
| EP (1) | EP1326860A1 (en) |
| JP (1) | JP2004511480A (en) |
| AU (1) | AU2001292137A1 (en) |
| WO (1) | WO2002030926A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL202812B1 (en) | 2000-08-21 | 2009-07-31 | Astrazeneca Ab | Quinazoline derivatives |
| US6849625B2 (en) | 2000-10-13 | 2005-02-01 | Astrazeneca Ab | Quinazoline derivatives with anti-tumour activity |
| WO2002036587A2 (en) | 2000-11-01 | 2002-05-10 | Cor Therapeutics, Inc. | Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| JP4307843B2 (en) | 2001-04-19 | 2009-08-05 | アストラゼネカ アクチボラグ | Quinazoline derivatives |
| US7501516B2 (en) | 2001-07-16 | 2009-03-10 | Astrazeneca Ab | Quinoline derivatives and their use as tyrosine kinase inhibitors |
| EP2280003B1 (en) | 2002-07-15 | 2014-04-02 | Symphony Evolution, Inc. | Process for preparing receptor-type kinase modulators |
| US7560558B2 (en) | 2002-08-23 | 2009-07-14 | Kirin Beer Kabushiki Kaisha | Compound having TGFβ inhibitory activity and medicinal composition containing the same |
| SI1562955T1 (en) | 2002-11-04 | 2008-06-30 | Astrazeneca Ab | Quinazoline derivatives as src tyrosine kinase inhibitors |
| GB0318422D0 (en) * | 2003-08-06 | 2003-09-10 | Astrazeneca Ab | Chemical compounds |
| DK2210607T3 (en) | 2003-09-26 | 2011-12-12 | Exelixis Inc | N- [3-fluoro-4 - ({6- (methyloxy) -7 - [(3-morpholin-4-ylpropyl) oxy] quinolin-4-yl} oxy) phenyl] -N '- (4-fluorophenyl) cyclopropane-1,1-dicarboxamide for the treatment of cancer |
| WO2005090332A1 (en) * | 2004-03-23 | 2005-09-29 | Banyu Pharmaceutical Co., Ltd | Substituted quinazoline or pyridopyrimidine derivative |
| US7829574B2 (en) * | 2008-05-09 | 2010-11-09 | Hutchison Medipharma Enterprises Limited | Substituted quinazoline compounds and their use in treating angiogenesis-related diseases |
| WO2010083414A1 (en) | 2009-01-16 | 2010-07-22 | Exelixis, Inc. | Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| UA108618C2 (en) | 2009-08-07 | 2015-05-25 | APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT | |
| WO2016016894A1 (en) | 2014-07-30 | 2016-02-04 | Yeda Research And Development Co. Ltd. | Media for culturing pluripotent stem cells |
| EP3914698A1 (en) | 2019-01-23 | 2021-12-01 | Yeda Research and Development Co. Ltd | Culture media for pluripotent stem cells |
| EP4076667A1 (en) | 2019-12-20 | 2022-10-26 | Erasca, Inc. | Tricyclic pyridones and pyrimidones |
| JP2023544450A (en) | 2020-09-23 | 2023-10-23 | エラスカ・インコーポレイテッド | Tricyclic pyridones and pyrimidone |
| US20230107642A1 (en) | 2020-12-18 | 2023-04-06 | Erasca, Inc. | Tricyclic pyridones and pyrimidones |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0584222B1 (en) | 1991-05-10 | 1997-10-08 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| US5721237A (en) | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| US5710158A (en) | 1991-05-10 | 1998-01-20 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| GB9323290D0 (en) * | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
| KR100225721B1 (en) | 1994-02-23 | 1999-10-15 | 디. 제이. 우드, 스피겔 알렌 제이 | 4-heterocyclyl-substitute quinazoline derivatives, processes for their preparation and their use as anti-cancer agents. |
| AU3217995A (en) | 1994-07-25 | 1996-02-22 | Pwa Ortmann Ag | Toilet paper package in the form of an extended paper strip |
| GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
| GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| US5747498A (en) * | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| US6046206A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
| WO1998002434A1 (en) | 1996-07-13 | 1998-01-22 | Glaxo Group Limited | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| AR012634A1 (en) | 1997-05-02 | 2000-11-08 | Sugen Inc | QUINAZOLINE BASED COMPOUND, FAMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, METHOD TO SYNTHESIZE IT, ITS USE, METHODS OF MODULATION OF THE DESERINE / TREONIN PROTEIN-KINASE FUNCTION AND IN VITRO METHOD TO IDENTIFY COMPOUNDS THAT MODULATE |
| ZA986729B (en) * | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
| TW436485B (en) | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
| CN1167422C (en) | 1999-02-10 | 2004-09-22 | 阿斯特拉曾尼卡有限公司 | Quinazoline derivatives as angiogenesis inhibitors |
| CA2384282A1 (en) | 1999-09-21 | 2001-03-29 | Astrazeneca Ab | Quinazoline compounds and pharmaceutical compositions containing them |
| DE60121931T2 (en) | 2000-04-07 | 2007-03-01 | Astrazeneca Ab | quinazoline |
| UA73993C2 (en) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition |
| PL202812B1 (en) | 2000-08-21 | 2009-07-31 | Astrazeneca Ab | Quinazoline derivatives |
| US6849625B2 (en) | 2000-10-13 | 2005-02-01 | Astrazeneca Ab | Quinazoline derivatives with anti-tumour activity |
| JP4307843B2 (en) | 2001-04-19 | 2009-08-05 | アストラゼネカ アクチボラグ | Quinazoline derivatives |
| WO2002092577A1 (en) | 2001-05-14 | 2002-11-21 | Astrazeneca Ab | Quinazoline derivatives |
| WO2002092579A1 (en) | 2001-05-14 | 2002-11-21 | Astrazeneca Ab | 4-anilinoquinazoline derivatives |
| WO2002092578A1 (en) | 2001-05-14 | 2002-11-21 | Astrazeneca Ab | Quinazoline derivatives |
| US7501516B2 (en) | 2001-07-16 | 2009-03-10 | Astrazeneca Ab | Quinoline derivatives and their use as tyrosine kinase inhibitors |
| WO2003047584A1 (en) | 2001-12-05 | 2003-06-12 | Astrazeneca Ab | Quinoline derivatives |
| AU2002347336A1 (en) | 2001-12-05 | 2003-06-17 | Astrazeneca Ab | Quinoline derivatives |
-
2001
- 2001-10-09 EP EP01972363A patent/EP1326860A1/en not_active Withdrawn
- 2001-10-09 WO PCT/GB2001/004497 patent/WO2002030926A1/en not_active Application Discontinuation
- 2001-10-09 JP JP2002534312A patent/JP2004511480A/en active Pending
- 2001-10-09 US US10/399,017 patent/US6939866B2/en not_active Expired - Fee Related
- 2001-10-09 AU AU2001292137A patent/AU2001292137A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6939866B2 (en) | 2005-09-06 |
| WO2002030926A1 (en) | 2002-04-18 |
| US20040044015A1 (en) | 2004-03-04 |
| EP1326860A1 (en) | 2003-07-16 |
| JP2004511480A (en) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002221047A1 (en) | Quinazolinone derivatives | |
| AU7860901A (en) | Quinazoline derivatives | |
| AU2001280099A1 (en) | 4-acylaminopyrazole derivatives | |
| AU2001230584A1 (en) | 1h-imidazopyridine derivatives | |
| AU2002212436A1 (en) | Quinazoline derivatives | |
| AU2960599A (en) | Quinazoline derivatives | |
| AUPR975601A0 (en) | Quinazolinone derivatives | |
| AU2001230537A1 (en) | Pyridoxazine derivatives | |
| AU2000267458A1 (en) | Hypercomputer | |
| AU2001281802A1 (en) | 6-phenylpyrrolopyrimidinedione derivatives | |
| AU2002352444A1 (en) | Quinazolinedione derivatives | |
| AU2001278790A1 (en) | 1h-imidazopyridine derivatives | |
| AU2001292137A1 (en) | Quinazoline derivatives | |
| AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
| AU2002212301A1 (en) | Diazacycloalkanedione derivatives | |
| AU2002212959A1 (en) | Cycloalkylfluorosulfonamide derivatives | |
| AU7419300A (en) | Quinazolinones | |
| AU2002215212A1 (en) | 1-methylcarbapenem derivatives | |
| AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
| AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
| AU2001254661A1 (en) | Aminosulfonylbiphenyl derivatives | |
| AU2001234313A1 (en) | Novel phenylheteroalkylamine derivatives | |
| AU2001242772A1 (en) | 3-substituted-4-pyrimidone derivatives | |
| AU2002214354A1 (en) | Neck-phone | |
| AU7654800A (en) | Quinazolinones |